Bizcommunity36m
Sanofi-Novavax deal in jeopardy as FDA halts vaccine approval
Full approval is crucial for Novavax to proceed with a $175m partnership deal with Sanofi, set to commence in the 2025-2026 ...
PharmExec5d
FDA Grants Fast Track Designation to Sanofi’s mRNA Chlamydia Vaccine
As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety of its novel mRNA vaccine in preventing chlamydia.
Clinical Advisor2d
Chlamydia Vaccine Candidate Gets Fast Track Status
The FDA has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.
pharmaphorum6d
FDA fast-tracks Sanofi's experimental chlamydia vaccine
Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...
Top Trump FDA official Brenner hits pause on Novavax Covid-19 vaccine decision
The move comes amid HHS Secretary Robert F. Kennedy Jr.’s decision to force out the top official responsible for reviewing ...
Medical Dialogues6d
Sanofi gets USFDA fast track designation for Chlamydia vaccine candidate
Paris: Sanofi has received the US Food and Drug Administration (USFDA) fast-track designation for its mRNA vaccine candidate ...
Pharmabiz6d
US FDA grants fast track designation to Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection
US FDA grants fast track designation to Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection: Paris Friday, March 28, 2025, 12:00 Hrs [IST] The US Food and Drug ...
SA Asks: How will changes at FDA impact vaccine makers?
Vaccine stocks have been under significant pressure in recent days following news that the FDA director who oversaw the ...